Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | CA9 | Q16790 | 3/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP51A1 | Q16850 | 4/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 6/20 | 0.35 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.35 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.35 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | SCN1A | P35498 | 1/20 | 0.31 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.31 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23854165 | 0.81 | CA1 (0.47) | CA1CA2CA9CA5ACA5B | |
| SCHEMBL13882617 | 0.81 | CA1 (0.47) | CA1CA2CA9CA5ACA5B | |
| SCHEMBL16748959 | 0.80 | CA1 (0.58) | CA1CA2CA9CA5ACA5B | |
| SCHEMBL14340571 | 0.77 | ALDH1A1 (0.50) | CA1CA2CA9CA5ACA5B | |
| SCHEMBL13475881 | 0.77 | CA1 (0.48) | CA1CA2CA9CA5ACA5B | |
| SCHEMBL30002551 | 0.76 | CA1 (0.52) | CA1CA2CA9CA5ACA5B | |
| SCHEMBL28837942 | 0.76 | CA1 (0.42) | CA1CA2CA9CA5ACA5B | |
| SCHEMBL13668357 | 0.74 | TP53 (0.42) | CA1CA2CA9CA5ACA5B | |
| SCHEMBL18845153 | 0.74 | CA1 (0.41) | CA1CA2CA9CA5ACA5B | |
| SCHEMBL29443898 | 0.74 | CA1 (0.41) | CA1CA2CA9CA5ACA5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110383538-A | Thin film electrode, resin layer forming ink, inorganic layer forming ink, and electrode printing apparatus | 株式会社理光 | 2019-10-25 | — | — | CN | disclosed |
| US-10098828-B2 | Cosmetic method for controlling odors | L'OREAL (FR) | 2018-10-16 | — | — | US | disclosed |
| US-20170360678-A1 | COSMETIC METHOD FOR CONTROLLING ODORS | L'OREAL (FR) | 2017-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10098828-B2 | Cosmetic method for controlling odors | OR51E2, AOX1, LPO | CA1 1122/4885CA2 1720/4885CA9 344/4885 |
| US-20170360678-A1 | COSMETIC METHOD FOR CONTROLLING ODORS | OR51E2, AOX1, LPO | CA1 1122/4885CA2 1720/4885CA9 344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.